Clinical Trial Update: A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea

View source ↗

Summary

A South Korea–focused clinical trial update shows Vedolizumab SC is being studied in adults with moderate-to-severe Ulcerative Colitis or Crohn's Disease, and t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Vedolizumab SC (vedolizumab)

Snippet

Sponsor: Takeda | Conditions: Ulcerative Colitis, Crohn's Disease | Status: RECRUITING